ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2017

Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation.

C B Resende et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.